Skip to main content

Breadcrumb

  1. Home

Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer

Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial

A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • …
  • Next page Next
  • Last page Last
Subscribe to